EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 3.0

Improving Pathological Assessment of Breast Cancer by Employing Array-Based Transcriptome Analysis

Zsuzsanna Mihály, Balázs Győrffy

Microarrays · 2013

DOI: 10.3390/microarrays2030228 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Microarrays, 2013. Verfasst von Zsuzsanna Mihály und 1 weiteren Autor:innen. Beteiligte Einrichtung: Deptartment of Pediatrics, Semmelweis University, Budapest H-1083, Hungary. zsuzsannamihaly@gmail.com. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer research has paved the way of personalized oncology with the introduction of hormonal therapy and the measurement of estrogen receptor as the first widely accepted clinical biomarker. The expression of another receptor—HER2/ERBB2/neu—was initially a sign of worse prognosis, but targeted therapy has granted improved outcome for these patients so that today HER2 positive patients have better prognosis than HER2 negative patients. Later, the introduction of multigene assays provided the pathologists with an unbiased assessment of the tumors’ molecular fingerprint. The recent FDA approval of complete microarray pipelines has opened new possibilities for the objective classification of breast cancer samples. Here we review the applications of microarrays for determining ER and HER2 status, molecular subtypes as well as predicting prognosis and grade for breast cancer patients. An open question remains the role of single genes within such signatures. Openly available microarray datasets enable the execution of an independent cross-validation of new marker and signature candidates. In summary, we review the current state regarding clinical applications of microarrays in breast cancer molecular pathology.

Schlagwörter

Stichwörter der Autor:innen

biomarkerbreast cancermicroarraymolecular subtypepredictionprognosis

Autor:innen und Institutionen

  • Deptartment of Pediatrics, Semmelweis University, Budapest H-1083, Hungary. zsuzsannamihaly@gmail.com.
  • Research Laboratory of Pediatrics and Nephrology, Hungarian Academy of Sciences, Budapest H-1083, Hungary. gyorffy@gyer1.sote.hu.

Zitieren

APA

Mihály, Z., & Győrffy, B. (2013). Improving Pathological Assessment of Breast Cancer by Employing Array-Based Transcriptome Analysis. Microarrays. https://doi.org/10.3390/microarrays2030228

Vancouver

Mihály Z, Győrffy B. Improving Pathological Assessment of Breast Cancer by Employing Array-Based Transcriptome Analysis. Microarrays. 2013. doi:10.3390/microarrays2030228

BibTeX
@article{Mihly2013,
  author = {Mihály, Zsuzsanna and Győrffy, Balázs},
  title = {Improving Pathological Assessment of Breast Cancer by Employing Array-Based Transcriptome Analysis},
  journal = {Microarrays},
  year = {2013},
  doi = {10.3390/microarrays2030228}
}
Kostenlos starten →